Mirjana Stanić Benić

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Top Venues

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Tatjana Zekić, Mirjana Stanić Benić
Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review. Rheumatology international (2022)
Tatjana Zekić, Mirjana Stanić Benić, Mislav Radic
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatology international 42 (10) (2022)